N-(4-(4-(5-Fluoropyrimidin-2-yl)piperazin-1-yl)phenyl)-6-methyl-8-phenylpyrrolo[1,2-a]pyrazine-1-carboxamide

Catalog No. :
ACDKCZ206
CAS No. :
2841463-83-8
Molecular Formula :
C29H26FN7O
Molecular Weight :
507.57

IUPAC Name:N-(4-(4-(5-fluoropyrimidin-2-yl)piperazin-1-yl)phenyl)-6-methyl-8-phenylpyrrolo[1,2-a]pyrazine-1-carboxamide

N-(4-(4-(5-Fluoropyrimidin-2-yl)piperazin-1-yl)phenyl)-6-methyl-8-phenylpyrrolo[1,2-a]pyrazine-1-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-(4-(5-Fluoropyrimidin-2-yl)piperazin-1-yl)phenyl)-6-methyl-8-phenylpyrrolo[1,2-a]pyrazine-1-carboxamide
IUPAC NameN-(4-(4-(5-fluoropyrimidin-2-yl)piperazin-1-yl)phenyl)-6-methyl-8-phenylpyrrolo[1,2-a]pyrazine-1-carboxamide
Molecular FormulaC29H26FN7O
Molecular Weight507.57
SMILESO=C(C1=NC=CN2C1=C(C3=CC=CC=C3)C=C2C)NC4=CC=C(N5CCN(C6=NC=C(F)C=N6)CC5)C=C4
InChI KeyMOSATOCKNQYTRF-UHFFFAOYSA-N
SynonymN-(4-(4-(5-fluoropyrimidin-2-yl)piperazin-1-yl)phenyl)-6-methyl-8-phenylpyrrolo[1,2-a]pyrazine-1-carboxamide;Pyrrolo[1,2-a]pyrazine-1-carboxamide, N-[4-[4-(5-fluoro-2-pyrimidinyl)-1-piperazinyl]phenyl]-6-methyl-8-phenyl-
CAS No.2841463-83-8

Synthetic Route by SureRoute

1. ACDKCZ206 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDKCZ206 route product structure diagram
    ACDKCZ2062841463-83-8
Inquiry

2. ACDKCZ206 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXFEN753 route compound structure diagram
    ACXFEN75362802-42-0 In Stock
  4. Then
  5. ACDKCZ206 route product structure diagram
    ACDKCZ2062841463-83-8
Inquiry

Comments (0)